Microbiologists have a rare opportunity to help shape future European biotechnology regulation. Applied Microbiology International (AMI) is calling on members to contribute as the European Commission seeks expert input on a proposed new Biotech Act.
The Act is designed to strengthen the competitiveness of Europe’s biotechnology sector while maintaining high standards for the protection of human health, animal health and the environment. As part of this initiative, amendments have been proposed to Directive 2001/18/EC, introducing a regulatory framework specifically tailored to genetically modified micro-organisms (GMMs). AMI wants to ensure the microbiology community has a strong voice in that conversation.
While the existing legislation covers all genetically modified organisms, much of it was originally developed with genetically modified plants in mind. The proposed amendments recognise that microorganisms present different scientific and regulatory challenges and opportunities, and aim to create a more proportionate, efficient system without compromising safety.
MICROBIOLOGY NEWS: Register with The Microbiologist for more free articles
As a learned society representing applied microbiologists across academia, industry and the public sector, Applied Microbiology International will be submitting a response to the consultation. To ensure that response reflects the breadth of expertise within our community, we are inviting members to share their views.
Opportunity for scientists
The Commission is not asking stakeholders to complete a standard questionnaire. Instead, it is seeking feedback on the proposed legislative amendments themselves. This provides an opportunity for scientists to highlight where proposals are well supported by current evidence, where clarification may be needed, and where emerging technologies should be considered.
Among the issues under discussion are:
- how genetically modified microorganisms should be defined;
- whether environmental risk assessment requirements are appropriate for microbial applications;
- proposals for indefinite market authorisations;
- new approaches to detection methods where conventional techniques are not technically feasible;
- the creation of a new category of “low-risk” GMMs with simplified authorisation procedures;
- circumstances in which post-market environmental monitoring may not be required; and
- the scientific expertise that should inform future technical guidance.
Who should take part?
You do not need to be a regulatory specialist to contribute. The AMI Policy Team has reviewed the consultation and identified the areas where member expertise would be particularly valuable. Whether you wish to comment on a single question or several, your practical experience and scientific insight can help strengthen AMI’s response.
Perhaps you have experience assessing environmental risks associated with microbial technologies, developing genetically modified microorganisms for industrial applications, or working with microbial detection methods. Equally valuable are perspectives on emerging areas such as synthetic biology, microbial ecology, antimicrobial resistance or environmental monitoring.
Even brief comments or examples drawn from your own work can provide useful evidence and help ensure that policymakers understand how the proposals may affect the microbiology community in practice.
Contributing is straightforward
AMI has prepared a working document containing background information on the proposed amendments together with a series of expert review questions to guide contributions.
Members are welcome to add comments directly to the shared document, including their name alongside any suggested additions so appropriate credit can be given - or alternatively submit feedback by email to the Policy Team.
The consultation response will focus specifically on the proposed amendments relating to genetically modified microorganisms, ensuring that AMI’s submission reflects the scientific expertise of its members.
Be heard
Policy decisions made today will influence the future regulatory landscape for biotechnology for years to come. By contributing your expertise, you can help shape a framework that both enables innovation and maintains the high standards of safety and environmental protection that underpin responsible biotechnology.
This is an opportunity for the microbiology community to demonstrate the value of evidence-based policy and ensure that legislation reflects the realities of modern microbiological research and application.
If you would like to contribute, please send your comments to the AMI Policy Team by Wednesday 29 July. Whether your feedback is detailed or brief, your expertise will help ensure AMI’s response represents the breadth and depth of knowledge within our community.
No comments yet